2 completed, 1 terminated. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Anti-Bacterial Agents: new trials by email Literature Review of Anti-Bacterial Agents trials Research Report on Anti-Bacterial Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD) | Phase 2 / Phase 3 | Completed | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | 12 | 2021-08-31 | 2025-08-11 |
| Phase IIa Clinical Study of N-Rephasin® SAL200 N-Rephasin® SAL200, Placebo - Staphylococcus Aureus Bacteremia, Anti-Bacterial Agents | Phase 2 | Terminated | Intron Biotechnology, Inc. | 25 | 2017-03-07 | 2021-10-06 |
| An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice Educational intervention, Educational intervention program - Respiratory Tract Infections, Anti-Bacterial Agents | Phase 1 / Phase 2 | Completed | University of Oslo | 118621 | 2006-01-01 | 2010-04-27 |
Kidney Failure, Chronic (1) · Peritonitis (1) · Respiratory Tract Infections (1)
Infections (2) · Chronic Disease (1) · Digestive System Diseases (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Intraabdominal Infections (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Peritoneal Diseases (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Respiratory Tract Diseases (1)
Aztreonam (1) · Early Intervention, Educational (1) · Meropenem (1)
Intron Biotechnology, Inc. (1) · Karl Landsteiner Insitute for Nephrology and Haemato-Oncology (1) · University of Oslo (1)
Austria (1) · Norway (1) · South Korea (1)
Hong-Bin Kim, M.D, PhD (1) · Martin F Wiesholzer, MD (1) · Svein Gjelstad, MD (1) · Wan Beom Park, M.D, PhD (1)
PMID 16776824, PMID 22491776, PMID 23299114, PMID 23894178, PMID 27242721, PMID 2875256, PMID 6939390